Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)-Reference-Cited by-同舟云学术

Plasma CCN2 (connective tissue growth factor; CTGF) is a potential biomarker in idiopathic pulmonary fibrosis (IPF)

Published:2011-11 Issue:23-24 Volume:412 Page:2211-2215
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

Kono Masato,Nakamura Yutaro,Suda Takafumi,Kato Masato,Kaida Yusuke,Hashimoto Dai,Inui Naoki,Hamada Etsuko,Miyazaki Osamu,Kurashita Syunsuke,Fukamachi Isamu,Endo Koki,Ng Poh-Sing,Takehara Kazuhiko,Nakamura Hirotoshi,Maekawa Masato,Chida Kingo

Publisher

Elsevier BV

Subject

Biochemistry, medical,Clinical Biochemistry,Biochemistry,General Medicine

Reference38 articles.

1. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification;Katzenstein;Am J Respir Crit Care Med,1998

2. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS);American Thoracic Society;Am J Respir Crit Care Med,2000

3. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001;American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias;Am J Respir Crit Care Med,2002

4. The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis;Nicholson;Am J Respir Crit Care Med,2000

5. Clinical significance of histological classification of idiopathic interstitial pneumonia;Flaherty;Eur Respir J,2002

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Survey of Dopamine Receptor D2 Antagonists as Retinal Antifibrotics;Journal of Ocular Pharmacology and Therapeutics;2024-08-29

2. PDE4B inhibition by nerandomilast: Effects on lung fibrosis and transcriptome in fibrotic rats and on biomarkers in human lung epithelial cells;British Journal of Pharmacology;2024-08-25

3. Drugs targeting CTGF in the treatment of pulmonary fibrosis;Journal of Cellular and Molecular Medicine;2024-05

4. Serum levels of the N-terminal fragment of connective tissue growth factor is a novel biomarker for chronic pancreatitis;Practical Laboratory Medicine;2024-05

5. Connective tissue growth factor enhances TGF-β1-induced osteogenic differentiation via activation of p38 MAPK in mesenchymal stem cells;Journal of Oral Biosciences;2024-03